A phase 1a/b, open-label, dose-escalation study of 225Ac-ABD147 for locally advanced or metastatic small cell lung cancer and large cell neuroendocrine carcinoma of the lung following platinum-based chemotherapy

ABD-147 - Abdera Therap

Babak Saboury1; Lisa Bodei2; Gary A. Ulaner3; Jowell Go4; Guanying Wang4; Charles M. Rudin2

Mar 26, 2025